posted on 2015-04-30, 03:12authored byKyle C. Wilcox, Matthew R. Marunde, Aditi Das, Pauline T. Velasco, Benjamin D. Kuhns, Michael T. Marty, Haoming Jiang, Chi-Hao Luan, Stephen G. Sligar, William L. Klein
Of fifteen compounds surviving dose-response potency testing, five commercially-available molecules were repurchased for further analysis. (a) The names and EC50 values of each are listed with the corresponding panel identifier. (b-f) Individual dose response curves and chemical structures corresponding to compounds listed in panel a. Vertical lines mark the EC50 values in each plot.